You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MDR-TB

Showing 1 - 25 of 1,125
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDR-TB, Immunotherapy Trial in Shanghai (V?2Vd2 T lymphocyte-based immunotherapy, Treatment regimens for MDR-TB)

Recruiting
  • MDR-TB
  • Immunotherapy
  • Vγ2Vδ2 T lymphocyte-based immunotherapy
  • Treatment regimens for MDR-TB
  • Shanghai, China
  • +1 more
Aug 8, 2022

MDR-TB Trial in Shanghai (PRS Regimen V, MDR-TB Treatment Regimen(WHO))

Recruiting
  • MDR-TB
  • PRS Regimen V
  • MDR-TB Treatment Regimen(WHO)
  • Shanghai, China
    Shanghai Pulmonary Hospital
Aug 4, 2022

MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)

Active, not recruiting
  • MDR-TB
  • Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
  • +9 more
  • Addis Ababa, Ethiopia
  • +12 more
Oct 12, 2022

Pre-XDR-TB Trial in Seoul (BPaL regimen)

Not yet recruiting
  • Pre-XDR-TB
  • BPaL regimen
  • Seoul, Songpa-gu, Korea, Republic of
    Asan Medical Center
Jul 19, 2022

Tuberculosis, Multidrug Resistant Trial in Chernivtsi, Ivano-Frankivs'k, Kharkiv (RUTI® Therapeutic vaccine, Matching RUTI®

Terminated
  • Tuberculosis, Multidrug Resistant
  • RUTI® Therapeutic vaccine
  • Matching RUTI® Placebo
  • Chernivtsi, Ukraine
  • +2 more
Jun 30, 2022

Tuberculosis, Multidrug-Resistant Trial in Dasmariñas, Hanoi (Delamanid, Levofloxacin, Bedaquiline)

Recruiting
  • Tuberculosis, Multidrug-Resistant
  • Dasmariñas, Philippines
  • +1 more
Jun 21, 2022

Tuberculosis, HIV Trial in Haiti, India, South Africa (Bedaquiline)

Recruiting
  • Tuberculosis
  • HIV Infections
  • Port-au-Prince, Haiti
  • +4 more
Jun 15, 2022

Multi-drug Resistant Tuberculosis Trial in China (18-month regimen containing 6 anti-TB drugs)

Completed
  • Multi-drug Resistant Tuberculosis
  • 18-month regimen containing 6 anti-TB drugs
  • Beijing, China
  • +19 more
Oct 10, 2022

Tuberculosis Trial in Cairo, Riyadh (13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB), 9 cis retinoic

Not yet recruiting
  • Tuberculosis
  • 13 cis retinoic acid, Minocycline, Chicroic Acid and Vitamin D for (MDR-TB)
  • +5 more
  • Cairo, Kafr El-sheikh, Egypt
  • +1 more
Oct 11, 2021

MDR-TB, HIV Trial in South Africa (NCM-Plus)

Active, not recruiting
  • MDR-TB
  • HIV
  • NCM-Plus
  • Westville, Durban, South Africa
  • +14 more
Nov 16, 2021

Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,

Active, not recruiting
  • Tuberculosis, Pulmonary
  • +5 more
  • Tbilisi, Georgia
  • +10 more
Jan 26, 2022

Tuberculosis, Rifampicin Resistant Tuberculosis Trial in Worldwide (Pretomanid, Optimized background regimen (OBR) for

Not yet recruiting
  • Tuberculosis
  • Rifampicin Resistant Tuberculosis
  • Pretomanid
  • Optimized background regimen (OBR) for multidrug-resistant TB (MDR-TB
  • Rio De Janeiro, Brazil
  • +6 more
Oct 18, 2022

Triage Test for All Oral DR-TB Regimen (TRiAD Study)

Recruiting
  • Drug Resistant Tuberculosis
  • +3 more
  • Xpert® MTB/XDR
  • Gulele, Addis Ababa, Ethiopia
  • +3 more
Jun 13, 2022

Expand New Drugs for TB [endTB]

Completed
  • Tuberculosis, Multidrug-Resistant
  • This is a non-intervention observational study
  • Abovyan, Armenia
  • +15 more
Jun 9, 2022

Tuberculosis, Thoracic Surgery, Tuberculosis, Pulmonary Trial in Tbilisi (therapeutical surgery for TB)

Active, not recruiting
  • Tuberculosis
  • +3 more
  • therapeutical surgery for TB
  • Tbilisi, Georgia
    National Center for Tuberculosis and Lung Diseases
Sep 9, 2022

Tuberculosis, Multidrug-Resistant Trial (Amikacin)

Not yet recruiting
  • Tuberculosis, Multidrug-Resistant
  • (no location specified)
Sep 23, 2022

Tuberculosis, Multidrug-Resistant, Infection, Bacterial, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline, Delamanid,

Active, not recruiting
  • Tuberculosis, Multidrug-Resistant
  • +2 more
  • Tbilisi, Georgia
  • +11 more
Feb 14, 2022

Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculoses Trial in Belarus, South

Recruiting
  • Multi-drug Resistant Tuberculosis
  • +2 more
  • Minsk, Belarus
  • +6 more
May 12, 2021

MDR-TB Trial in Kibong'oto (Therapeutic drug monitoring (TDM))

Completed
  • MDR-TB
  • Therapeutic drug monitoring (TDM)
  • Kibong'oto, Tanzania
    Kibong'oto infectious diseases hospital
Oct 28, 2020

Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline 100 MG, Delamanid 50 MG

Recruiting
  • Tuberculosis, Multidrug-Resistant
  • +5 more
  • Bedaquiline 100 MG
  • +4 more
  • Pune, India
  • +9 more
Mar 2, 2022

Tuberculosis Trial in Bergen, Oslo (etoricoxib, H56:IC31)

Completed
  • Tuberculosis
  • Bergen, Norway
  • +1 more
Apr 7, 2022

Tuberculosis, MDR Trial in Worldwide (Delamanid (DLM), Isoniazid (INH), Pyridoxine (vitamin B6))

Recruiting
  • Tuberculosis, MDR
  • Delamanid (DLM)
  • +2 more
  • Gaborone, South-East District, Botswana
  • +26 more
Sep 22, 2022

Pre-Extensively Drug-Resistant Pulmonary TB, Treatment Intolerant Multidrug-Resistant Pulmonary TB, Non-responsive

Recruiting
  • Pre-Extensively Drug-Resistant Pulmonary TB
  • +2 more
  • Agra, Uttarpradesh, India
    S N Medical College
Nov 8, 2021

Tuberculosis Research of INA-RESPOND On Drug Resistance

Completed
  • Lung Tuberculosis
  • MDR TB
  • No Intervention
  • Denpasar, Bali, Indonesia
  • +6 more
Nov 17, 2021

Multi-drug Resistant Tuberculosis Trial in Lambarene (Km+ Mfx+ Pto + H + Cfz +E+Z)

Recruiting
  • Multi-drug Resistant Tuberculosis
  • Km+ Mfx+ Pto + H + Cfz +E+Z
  • Lambarene, Please Select, Gabon
    Centre de Recherches Médicales de Lambaréné
Jul 26, 2021